Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia

Diabetes Mellitus Clinical Trial

Official title:

Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03665870
• Other study ID #: UAB-CHSP-2017-1
• Status: Completed
• Phase: N/A
• Start date: October 1, 2018
• Est. completion date: July 20, 2020

Study information

• Verified date: July 2020
• Source: University of Alabama at Birmingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to standardize and evaluate the benefits of the Prevention to Intervention program offered by the Birmingham Fire and Rescue Service. This will accomplished by standardizing the educational materials used, offering phone based follow-up and pre-post data collection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: July 20, 2020
• Est. primary completion date: May 24, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

1. Be a citizen of Birmingham

2. Be 18 years or older

3. Receive Dextrose-50 IV (intravenous treatment provided by EMS personnel for hypoglycemia)

4. Understand and speak English

Exclusion Criteria:

a) Enrolled currently in any diabetes related educational programs

Related Conditions & MeSH terms

• Diabetes Mellitus
• Hypoglycemia
• Hypoglycemia Acute
• Hypoglycemia Unawareness

Intervention

Behavioral:
• Hypoglycemia Education
Two in-person visits to the home of the participant and 4 phone calls will be conducted to provided education on prevention of hypoglycemia.

Locations

Country	Name	City	State
United States	Birmingham Fire and Rescue Service	Birmingham	Alabama

Sponsors (2)

Lead Sponsor	Collaborator
University of Alabama at Birmingham	Birmingham Fire and Rescue Service

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Fear of Hypoglycemia	One of the most important impact of hypoglycemia, is non-compliance to diabetes treatment due to the fear of hypoglycemia. This would be measured using the "Hypoglycemia Scale: FH-15" scale.	Through study completion, an average of 8 weeks
Secondary	Self Efficacy	Measured using the "Perceived Diabetes Self-Management Scale".	Pre and Post (after 8 weeks)Through study completion, an average of 8 weeks
Secondary	Knowledge of Diabetes	Measured using the "The Knowledge in Low Literacy in Diabetes Knowledge Assessment Scale"	Through study completion, an average of 8 weeks